| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/12/2013 | CN103142472A Ginkgolide B composition and preparation method thereof |
| 06/12/2013 | CN102526352B Medicine for treating pediatric hernia and preparing method thereof |
| 06/12/2013 | CN102526108B Method for commercial production of bezoar |
| 06/12/2013 | CN102309562B Preparation method of taste-masked suspension granules of Gegenqinlian decoction |
| 06/12/2013 | CN102274350B Traditional Chinese medicine for treating hernia |
| 06/12/2013 | CN102250181B Polyhydroxy steroid compounds and purpose thereof |
| 06/12/2013 | CN102240316B Method for extracting anthocyanin containing extract from cowberry |
| 06/12/2013 | CN102106805B Cymipristone solid preparation and preparation methods thereof |
| 06/12/2013 | CN101983072B Mineral absorption accelerator and iron deficiency anemia improver or food composition |
| 06/12/2013 | CN101932575B Piperidine derivative |
| 06/12/2013 | CN101906418B Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 06/12/2013 | CN101835480B Ligand agent for peroxisome proliferator-activated receptor (PPAR) |
| 06/12/2013 | CN101600719B Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol |
| 06/12/2013 | CN101600683B Therapeutic compounds |
| 06/12/2013 | CN101573333B Inhibitors of histone deacetylase |
| 06/12/2013 | CN101481325B Basic amino acid metalloproteinase inhibitor and use thereof |
| 06/12/2013 | CN101273013B Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 06/11/2013 | US8461212 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/11/2013 | US8461109 Method of enhancing the acceptance and/or healing of a skin graft |
| 06/11/2013 | US8460931 Neural progenitor cells derived from embryonic stem cells |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/11/2013 | CA2469336C Guanidinium transport reagents and conjugates |
| 06/11/2013 | CA2437453C Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/11/2013 | CA2426987C Human cord blood derived unrestricted somatic stem cells (ussc) |
| 06/11/2013 | CA2406839C G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
| 06/06/2013 | WO2013081154A1 Agent for reducing adverse side effects of kinase inhibitor |
| 06/06/2013 | WO2013081147A1 Whitening cosmetic |
| 06/06/2013 | WO2013081146A1 Anti-wrinkle cosmetic |
| 06/06/2013 | WO2013081118A1 Compound having read-through activity |
| 06/06/2013 | WO2013081094A1 Imidazo[1,2-a]pyridine derivative and use thereof for medical purposes |
| 06/06/2013 | WO2013081016A1 Purinone derivative hydrochloride |
| 06/06/2013 | WO2013080999A1 Agent for inhibiting expression of npc1l1 and/or lipg mrna and agent for preventing and/or treating obesity |
| 06/06/2013 | WO2013078511A1 Anti-npy and pyy antibodies and uses thereof |
| 06/06/2013 | US20130144056 Human Adam-10 Inhibitors |
| 06/06/2013 | US20130143970 Medicinal preparation particularly for the treatment of slipped discs hernias |
| 06/06/2013 | US20130143281 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 06/06/2013 | US20130142891 Fatigue-relieving herbal extracts and beverages comprising the same |
| 06/06/2013 | US20130142756 Methods of improving central nervous system functioning |
| 06/06/2013 | CA2857150A1 Purinone derivative hydrochloride |
| 06/05/2013 | EP2599868A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-Met AND USE THEREOF |
| 06/05/2013 | EP2599776A1 Therapeutic agent for neurological diseases |
| 06/05/2013 | EP2599775A1 Ethinyl-pyrazole derivative |
| 06/05/2013 | EP2599774A1 Condensed ring pyridine compound |
| 06/05/2013 | EP2599503A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 06/05/2013 | EP2599493A1 Antimicrobial activity enhancing agent |
| 06/05/2013 | EP2599490A1 Anti-fatigue composition, formulation and use thereof |
| 06/05/2013 | EP2599489A1 AChE antisense deoxyoligonucleotide as an anti-inflammatory agent |
| 06/05/2013 | EP2599487A1 Therapeutic agent or prophylactic agent for neuropathic pain |
| 06/05/2013 | EP2599393A1 Oily preparations of and with lecithinen without ether phospholipids for protective, dietary, cosmetic compositions or remedy for sensitive persons |
| 06/05/2013 | EP2598134A1 Composition and method for photodynamic disinfection |
| 06/05/2013 | CN103140466A Process for preparing compound by novel sandmeyer-like reaction using nitroxide radical compound as reaction catalyst |
| 06/05/2013 | CN103140226A Preparation for treatment of spinal cord injury |
| 06/05/2013 | CN103140221A Novel heterocyclic derivatives and pharmaceutical composition containing same |
| 06/05/2013 | CN103130739A Compounds having thrombopoietin receptor agonism |
| 06/05/2013 | CN103127100A Formulation and method for vascular permeability-related diseases or conditions |
| 06/05/2013 | CN103127027A Polysaccharide sulphate dropping pill |
| 06/05/2013 | CN103127013A Polysaccharide sulphate lipidosome tablet |
| 06/05/2013 | CN103126971A Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
| 06/05/2013 | CN102370635B Application and preparation method of novel nardosinone |
| 06/05/2013 | CN102056629B A photosensitising composition and its uses |
| 06/05/2013 | CN101978990B Schisandra extract and preparation method and application thereof |
| 06/05/2013 | CN101967168B Triterpenoid saponin derivative and preparation method and application thereof |
| 06/05/2013 | CN101921725B Converter for inhibiting hen somatostatin action through oral immunization and application thereof |
| 06/05/2013 | CN101906104B 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 06/05/2013 | CN101821229B Tricyclic amine compound |
| 06/05/2013 | CN101679363B Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same |
| 06/05/2013 | CN101654672B RNA interference mediating small RNA molecules |
| 06/05/2013 | CN101597280B Compound used as seven-pass transmembrane protein and based on sag structure |
| 06/05/2013 | CN101535289B Novel phenylacetic acid derivative |
| 06/05/2013 | CN101460624B Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same |
| 06/05/2013 | CN101448411B Guava leaf extract powder and method for production thereof |
| 06/04/2013 | US8455629 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 06/04/2013 | US8455536 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 06/04/2013 | US8455517 Method of using diketopiperazines and composition containing them |
| 06/04/2013 | US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455464 Dextrin containing compositions for prevention of adhesions |
| 06/04/2013 | US8454987 Biocompatible transparent sheet, method for producing the same, and cultured cell sheet used the same sheet |
| 06/04/2013 | CA2542609C Novel indazole derivatives |
| 06/04/2013 | CA2325735C Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation |
| 05/30/2013 | WO2013078393A1 Treating bladder cancer patients and identifying bladder cancer patients responsive to treatment |
| 05/30/2013 | WO2013077228A1 Impdh inhibitor having microrna as active component |
| 05/30/2013 | WO2013077186A1 Activity modulator, medicinal agent comprising same, use of cd300a gene-deficient mouse, and anti-cd300a antibody |
| 05/30/2013 | WO2013076516A1 1,4- dihydropyridine derivatives with hsp modulating activity |
| 05/30/2013 | WO2013022092A9 Heptamer-type small guide nucleic acid capable of inducing apoptosis of human hematologic cancer cells |
| 05/30/2013 | US20130137758 Akt activity specifically inhibiting polypeptide |
| 05/30/2013 | CA2854252A1 1,4-dihydropyridine derivatives with hsp modulating activity |
| 05/29/2013 | EP2597088A1 P2x4 receptor antagonist |
| 05/29/2013 | EP2597084A1 N-hydroxyformamide derivative and pharmaceutical containing same |
| 05/29/2013 | EP2595635A1 Polydeoxyribonucleotides (pdrns) for use in the treatment of metabolic and/or lactic acidosis and polydeoxyribonucleotide-based compositions for the aforesaid use |
| 05/29/2013 | EP2595624A2 Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects |
| 05/29/2013 | EP2595623A1 Use of delta tocopherol for the treatment of lysosomal storage disorders |
| 05/29/2013 | CN1582165B Antibodies to CD40 |
| 05/29/2013 | CN103120772A Traditional Chinese medicine composition for treating ephidrosis |
| 05/29/2013 | CN103120726A Traditional Chinese medicine composition for improving weaned pig growth performance and preparation method thereof |
| 05/29/2013 | CN103120674A Application of Eryngiolide A in preparation of MAO (Monoamine Oxidottom) inhibitor |
| 05/29/2013 | CN103120673A Application of Aphanamixoid A to preparation of monoamine oxidase (MAO) inhibitor |